Press releases

Largest randomized trial to compare the use of drug-eluting stents to bare-metal stents for AMI patients

Company presents one-year clinical data at TCT on its platinum chromium paclitaxel-eluting coronary stent from PERSEUS trial

Results of TAXUS ATLAS clinical program presented at TCT

Nine-month results from PLATINUM clinical program presented at TCT

Indications are important additions, especially as diabetes prevalence continues to increase worldwide

Offers first FDA-approved non-drug procedure for the treatment of severe asthma

FDA approval is based on results from the Company's landmark MADIT-CRT trial

Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems

Company to participate in the September 14th conference in New York City; live webcast and replay will be available

Presentations to feature Boston Scientific's pelvic floor reconstruction systems and mid-urethral sling systems

Resolution "marks a major milestone in our journey of continuous quality improvement," said Ray Elliott, President and Chief Executive Officer

EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent

Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads

Company to participate in the August 5th conference in New York; live webcast and replay will be available

Company expands market-leading family of neurovascular stents

"I am proud of the way the organization executed in a number of key areas during the quarter," said Ray Elliott, President and CEO

Trial data to help develop a clinical alert that identifies the early onset of worsening heart failure

Company to webcast its conference call with Q2 2010 financial results and business highlights on July 21

Two new splitters allow multi-site placement of up to four spinal cord stimulation leads

Refinancing to help strengthen Company’s capital structure and provide enhanced capacity to fund acquisitions and other investments in technologies

Longer balloons provide physicians more options for treating peripheral artery disease

Women experienced a 70 percent reduction in heart failure events compared to a 35 percent reduction for men

Company to participate in the healthcare conference on June 24 in Boston; live webcast and replay will be available

Presentations to include results of the MADIT-CRT trial and the ALTITUDE clinical science program

CE Mark approval includes specific indication for treatment of diabetic patients